A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial. JNJ-6420 exposure and clinical activity.

French technological solutions company Elwave announced that their Octopulse underwater electromagnetic sensor mounted on Royal IHC’s crawler is performing sea trials during the SeaSEC25 Challenge.

After the signing of definitive documentation, BlackRock will provide a minority investment commitment to the venture. IHC also announced that the company will be chaired by Dr. Sultan Ahmed Al Jaber, ...

BlackRock is backing a $1 billion, artificial intelligence-backed reinsurance platform launched by IHC and headquartered in Abu Dhabi. The new platform, which is yet to be named, will serve global ...

2. Immunohistochemistry (IHC) staining confirmed limited ITGB4 expression in normal tissue but high expression in tumor tissues from patients with CRC, sq-NSCLC, HNSCC and ESCC. 3. ITGB4 antibody ...

24 CD34 + cells were purified by an autoMACS separator (Miltenyi Biotec, Lund, Sweden), using magnetic beads‐coated mouse anti human CD34 antibody (Ab) and a CD34 Cell isolation kit (Miltenyi Biotec), ...

Department of Discovery & Development Technologies, The Healthcare Business of Merck KGaA, Darmstadt 64293, Germany ...

A neutralizing antibody therapy targeting the conserved stalk region of the H5N1 hemagglutinin protein reduced disease severity and prevented death in monkeys exposed to avian flu.

Abstract: Background: Over a decade, tissues dissected adjacent to primary tumors have been considered “normal” or healthy samples (NATs). However, NATs have recently been discovered to be distinct ...

A, CD34−/CD45− cells show fibroblastic morphology typical ... adductor muscle sections were stained with a goat anti-mouse platelet–endothelial cell adhesion molecule (PECAM) antibody (Santa Cruz).